Our Team Members

I'm a title. ​Click here to edit me.

Dr. Alexandra Bause

Co-Founder, Apollo Health Ventures

Alexandra is a Co-Founder and Investment Director at Apollo Health Ventures, an early stage investment fund focused on developing interventions that enhance human health and longevity.

Image-empty-state.png

Dr. Aubrey de Grey

Chief Science Officer, SENS Research Foundation

Dr. Aubrey de Grey is a biomedical gerontologist based in Mountain View, California, USA, and is the Chief Science Officer of SENS Research Foundation, a California-based 501(c)(3) biomedical research charity that performs and funds laboratory research dedicated to combating the aging process.

Image-empty-state.png

Dr. Emil Kendziorra

President of the Board / Trustee, European Biostasis Foundation

Emil is the President of the Board and a trustee at European Biostasis Foundation based in Switzerland and the CEO at Tomorrow Biostasis GmbH based in Germany.

Image-empty-state.png

Dr. Eric Verdin

President & CEO, Buck Institute for Research on Aging

Dr. Eric Verdin is the President and Chief Executive Officer of the Buck Institute for Research on Aging. A native of Belgium, Dr. Verdin received his Doctorate of Medicine from the University of Liege and completed additional clinical and research training at Harvard Medical School.

Image-empty-state.png

Dr. Joon Yun

President and Managing Partner, Palo Alto Investors

Dr. Joon Yun is President and Managing Partner of Palo Alto Investors, LP, a hedge fund founded in 1989 with approximately $2 billion in assets invested in healthcare.

Image-empty-state.png

Dr. Nir Barzilai

Director, Institute for Aging Research, Albert Einstein College of Medicine

Dr. Nir Barzilai serves as director of the Institute for Aging Research at the Albert Einstein College of Medicine. In addition, he is a founder and board member of CohBar Inc.

Image-empty-state.png

Dr. Ronjon Nag

Founder, R42 Institute

Ronjon Nag is founder of R42 Institute and is an Interdisciplinary Distinguished Careers Institute Fellow at Stanford University where he teaches courses for AI in healthcare. He has invented and deployed artificial intelligence systems for over three decades.

Image-empty-state.png

Dr. Tobias Reichmuth

Host, Longevity Investors Conference

Tobias Reichmuth is a serial entrepreneur and investor. Since 2019 he takes part in “Höhle der Löwen”, the Swiss version of the TV investor show “Shark-Tank”.

Image-empty-state.png

Gregory Hung

CIO, The Singularity Group

Gregory Hung is The Singularity Group’s (TSG) Chief Investment Officer, a Swiss investment boutique and research house dedicated to making applied innovation investable across industries.

Image-empty-state.png

Jim Mellon

Co-Founder and Chairman of Juvenescence

Jim Mellon is a British entrepreneur and investor with a wide range of interests. Through his private investment company, Burnbrae Group, he has substantial real estate holdings in Germany and the Isle of Man, as well as holdings in private and public companies.

Image-empty-state.png

Marc P. Bernegger

Host, Longevity Investors Conference

Marc is a serial entrepreneur who co-founded the party platform usgang.ch in his 20s (trade sale to Axel Springer Media).

Image-empty-state.png

Margaretta Colangelo

Co-founder & Managing Director Deep Knowledge Group

Margaretta is Co-founder and Managing Director of Deep Knowledge Group, an international consortium of commercial and non-profit organizations active in DeepTech, Longevity, and Frontier Technologies.

Image-empty-state.png

Patrick Burgermeister

Partner at Kizoo 

Patrick Burgermeister is an expert in life science investing with a double background in molecular biology (Biozentrum Basel) and business administration (HSG Sankt Gallen).

Image-empty-state.png

Ph.D., A.O. David A. Sinclair

Professor, Harvard University

David Sinclair is a tenured Professor of Genetics at Harvard Medical School. He is best known for his work on genes and small molecules that delay aging by boosting the body’s defenses and for being the first reprogram and rejuvenate tissuesin vivo.

Image-empty-state.png

Phil Newman

Editor-in-Chief, Longevity.Technology

Phil Newman is Editor in Chief of www.Longevity.Technology, the key daily news platform for Longevity investment, research and new business. 

Image-empty-state.png

Prof. Andrew J. Scott

Professor of Economics, London Business School

Andrew J. Scott is Professor of Economics, former Deputy Dean at London Business School and Research Fellow at the Centre for Economic Policy Research.

Image-empty-state.png

Prof. João Pedro de Magalhães

Integrative Genomics of Ageing Group, University of Liverpool

Prof de Magalhaes graduated in Microbiology in 1999 from the Escola Superior de Biotecnologia in his hometown of Porto, Portugal, and then obtained his PhD in 2004 from the University of Namur in Belgium.

Image-empty-state.png

Sabinije von Gaffke

Moderator

Sabinije von Gaffke is an internationally praised and awarded Moderator, Speaker, Entrepreneur and Impact Diplomat at the intersection of Tech, Leadership, Sustainability, Health, Science and Human Potential.

Image-empty-state.png